Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga

Sabrina Pricl,

doi:10.1515/EJNM.2009.2.1.22

Home Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga

Article

Licensed

Unlicensed Requires Authentication

Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga

Sabrina Pricl,

Published/Copyright: January 1, 2009

Published by

Become an author with De Gruyter Brill

Author Information

From the journal European Journal of Nanomedicine Volume 2 Issue 1

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Pricl,, Sabrina. "Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga" European Journal of Nanomedicine, vol. 2, no. 1, 2009, pp. 22-30. https://doi.org/10.1515/EJNM.2009.2.1.22

Pricl,, S. (2009). Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga. European Journal of Nanomedicine, 2(1), 22-30. https://doi.org/10.1515/EJNM.2009.2.1.22

Pricl,, S. (2009) Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga. European Journal of Nanomedicine, Vol. 2 (Issue 1), pp. 22-30. https://doi.org/10.1515/EJNM.2009.2.1.22

Pricl,, Sabrina. "Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga" European Journal of Nanomedicine 2, no. 1 (2009): 22-30. https://doi.org/10.1515/EJNM.2009.2.1.22

Pricl, S. Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga. European Journal of Nanomedicine. 2009;2(1): 22-30. https://doi.org/10.1515/EJNM.2009.2.1.22

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 2009-01

Published in Print: 2009-01

You are currently not able to access this content.

Articles in the same Issue

Editorial: Nanomedicine: shaping the future of medicine
Editorial: The 2nd European Clinical Nanomedicine Conference is ahead
Unsolved Medical Problems: Unresolved Problems in Cardiovascular Medicine waiting for Nanomedical Solutions
Technologies at Hand: Measuring the intrinsic nanomechanics of molecular interactions with microcantilever sensors
Preclinical Nanomedicine: Fluorescence in Clinical Nanometrology: its Potential Role in Diabetes Research and Management
Impressum
Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga
Implications of Nanomedicine: The Spiritualization of Science, Technology, and Education in a One-World Society
Unsolved Medical Problems: Blood-brain barrier in neurodegenerative diseases: perspectives for Nanomedicine
Clinical Nanomedicine: Nanomedical aproaches in Parkinson’s disease

Search journal Search the content of this journal

https://doi.org/10.1515/EJNM.2009.2.1.22

Articles in the same Issue

Editorial: Nanomedicine: shaping the future of medicine
Editorial: The 2nd European Clinical Nanomedicine Conference is ahead
Unsolved Medical Problems: Unresolved Problems in Cardiovascular Medicine waiting for Nanomedical Solutions
Technologies at Hand: Measuring the intrinsic nanomechanics of molecular interactions with microcantilever sensors
Preclinical Nanomedicine: Fluorescence in Clinical Nanometrology: its Potential Role in Diabetes Research and Management
Impressum
Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga
Implications of Nanomedicine: The Spiritualization of Science, Technology, and Education in a One-World Society
Unsolved Medical Problems: Blood-brain barrier in neurodegenerative diseases: perspectives for Nanomedicine
Clinical Nanomedicine: Nanomedical aproaches in Parkinson’s disease